How are Ziprasidone adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Ziprasidone, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ziprasidone is flagged as the suspect drug causing the adverse event.
What are the most common Ziprasidone adverse events reported to the FDA?
Somnolence | 581 (1.63%) |
Tardive Dyskinesia | 546 (1.54%) |
Insomnia | 531 (1.49%) |
Tremor | 527 (1.48%) |
Drug Ineffective | 503 (1.42%) |
Anxiety | 481 (1.35%) |
Weight Increased | 455 (1.28%) |
Feeling Abnormal | 451 (1.27%) |
Depression | 414 (1.16%) |
Agitation | 400 (1.13%) |
Dystonia | 372 (1.05%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Ziprasidone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ziprasidone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Ziprasidone adverse events reported to the FDA?
Neurological | 2947 (8.29%) |
Movement Disorders | 2596 (7.3%) |
Anxiety Disorders | 1520 (4.28%) |
Therapeutic And Nontherapeutic Effe... | 1106 (3.11%) |
Gastrointestinal Signs | 898 (2.53%) |
Cardiac Arrhythmias | 871 (2.45%) |
Respiratory | 832 (2.34%) |
Suicidal And Self-injurious Behavio... | 832 (2.34%) |
Cardiac And Vascular Investigations | 805 (2.27%) |
Physical Examination Topics | 804 (2.26%) |
Medication Errors | 745 (2.1%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Ziprasidone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ziprasidone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Ziprasidone, according to those reporting adverse events to the FDA?
Bipolar Disorder | 1599 |
Schizophrenia | 913 |
Ill-defined Disorder | 634 |
Depression | 480 |
Psychotic Disorder | 467 |
Schizoaffective Disorder | 377 |
Show More |
Label | Labeler | Effective |
---|---|---|
Geodon | State of Florida DOH Central Pharmacy | 01-JUN-10 |
Geodon | Physicians Total Care, Inc. | 29-JUN-10 |
Geodon | STAT RX USA LLC | 09-JUL-10 |
Geodon | Rebel Distributors Corp | 28-SEP-10 |
Geodon | Unit Dose Services | 06-DEC-10 |
Geodon | REMEDYREPACK INC. | 20-DEC-10 |
Geodon | REMEDYREPACK INC. | 20-DEC-10 |
Geodon | REMEDYREPACK INC. | 20-DEC-10 |
Geodon | REMEDYREPACK INC. | 20-DEC-10 |
Ziprasidone Hydrochloride | Apotex Corp. | 09-DEC-11 |
Ziprasidone Hydrochloride | Golden State Medical Supply, Inc. | 09-JAN-12 |
Ziprasidone Hydrochloride | LUPIN PHARMACEUTICALS INC | 15-FEB-12 |
Ziprasidone Hydrochloride | Major Pharmaceuticals | 06-MAR-12 |
Ziprasidone Hydrochloride | Rebel Distributors Corp | 13-MAR-12 |
Geodon | Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC | 27-MAR-12 |
Geodon | Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC | 11-JUN-12 |
Geodon | Cardinal Health | 28-JUN-12 |
Ziprasidone Hydrochloride | Wockhardt Limited | 20-JUL-12 |
Ziprasidone Hydrochloride | Wockhardt USA LLC. | 20-JUL-12 |
Ziprasidone Hydrochloride | American Health Packaging | 02-AUG-12 |
Ziprasidone | Greenstone LLC | 23-OCT-12 |
Ziprasidone | REMEDYREPACK INC. | 04-JAN-13 |
Ziprasidone | REMEDYREPACK INC. | 08-JAN-13 |
Ziprasidone Hydrochloride | REMEDYREPACK INC. | 08-FEB-13 |
Ziprasidone Hydrochloride | REMEDYREPACK INC. | 08-FEB-13 |
Ziprasidone Hydrochloride | REMEDYREPACK INC. | 08-FEB-13 |
Ziprasidone Hydrochloride | REMEDYREPACK INC. | 15-FEB-13 |
Geodon | Roerig | 08-MAR-13 |
Ziprasidone | REMEDYREPACK INC. | 27-MAR-13 |
Ziprasidone Hydrochloride | Apotex Corp. | 01-APR-13 |
Ziprasidone Hydrochloride | Dr. Reddy's Laboratories Limited | 05-APR-13 |
Ziprasidone Hydrochloride | REMEDYREPACK INC. | 08-APR-13 |
Ziprasidone Hydrochloride | Sandoz Inc | 12-APR-13 |
Ziprasidone | REMEDYREPACK INC. | 02-MAY-13 |
What Ziprasidone safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Ziprasidone. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Ziprasidone.